Once a promising antibody-based therapeutic has been identified, further steps remain in order to characterize it and ensure it performs its intended purpose in a safe and dependable way. Techniques such as peptide mapping, post-translational modification analysis, intact mass analysis, and others give valuable information on whether a candidate is a viable option for preclinical trials. In this phase, learn about the latest techniques and solutions being applied to candidate characterization.